Authors’ Correction Letter
نویسندگان
چکیده
منابع مشابه
Letter to the Editor: Authors' Response.
Thank you for the opportunity to respond to the concerns of Dr Reneman and colleagues about our paper, Kersnovske et al. [13]. Dr Reneman and colleagues have raised two issues that we address below. Their first concern relates to the use of experts for the purpose of validation. We assume the authors are not concerned with the use of experts as a method of content validation, per se, as this is...
متن کاملLetter to the editor: Authors' reply
To the Editor: We welcome the interest and enthusiasm of Halber et aL (1997) in the nonparametric randomization test that we described (Holmes et aL, 1996) not least because they called their program 'Sherlock', However, as the great detective would surely have pointed out, there are a num ber of flaws in the article that led the authors to an incorrect primary conclusion, that our test "is a ...
متن کاملAuthors' response to letter to the editor.
We thank Drs. Mandal and Goel for their interest in our work, but we disagree with their interpretation of the literature compared with our findings. While Waldert and associates did indeed find a correlation between a longer delay to nephroureterectomy (NUx) and more advanced stage, they did not report metastasis-free survival. Moreover, they found no difference in cancer-specific survival. Th...
متن کاملErratum: Correction to Authors Names
Copyright © 2012 by Korean Society of Otorhinolaryngology-Head and Neck Surgery. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Clinical an...
متن کاملCorrection : Serine Proteases in Histone Deacetylase Inhibitor – Induced Apoptosis – Letter
tivatin In an elicite obser induc trigge butyr toxic dition 10 da seeme prote rather If th TSA o idea We fo itory tion u inhibi with tone deacetylase inhibitors (HDACi) are a new of targeted antitumor agents (1). They exert their y against cancer cells by stimulating differentiation, ibiting proliferation, and by inducing apoptosis. ugh the latter has been extensively studied, our rstanding of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Sex Research
سال: 2016
ISSN: 0022-4499,1559-8519
DOI: 10.1080/00224499.2016.1140487